Condition: Cardiogenic Shock · Sponsor: Barts & The London NHS Trust
The aim of this project is to understand the heterogeneity of both the immune consequences and treatment responses in CS. We will explore this heterogeneity through identification of transcriptomic sub-phenotypes and their association with outcomes, including therapeutic responses.
This description comes directly from the study's public registry record.
Alastair Proudfoot · 02037658707 · alastair.proudfoot1@nhs.net
Mervyn Andiapen · 02037658707 · mervyn.andiapen@nhs.net
Always discuss trial participation with your own doctor first.
| Barts Health NHS trust | London, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05728359